Loading...
•
Dec 31, 2022
Stryker Q4 2022 Earnings Report
Stryker reported a net sales increase of 10.7% and an organic net sales increase of 13.2% for the fourth quarter of 2022.
Key Takeaways
Stryker reported strong fourth-quarter results with a 10.7% increase in net sales, reaching $5.2 billion, and a 13.2% increase in organic net sales. Adjusted EPS increased by 10.7% to $3.00. The company anticipates continued sales momentum in 2023.
Net sales increased by 10.7% to $5.2 billion.
Organic net sales increased by 13.2%.
Reported EPS decreased 15.0% to $1.47.
Adjusted EPS increased 10.7% to $3.00.
Forward Guidance
Stryker expects 2023 organic net sales growth to be in the range of 7.0% to 8.5% and adjusted net earnings per diluted share to be in the range of $9.85 to $10.15.
Positive Outlook
- Expects 2023 organic net sales growth to be in the range of 7.0% to 8.5%.
- Adjusted net earnings per diluted share to be in the range of $9.85 to $10.15.
- Based on the steady progress of pricing actions, the impact of price to be between 0% and -0.5%.
- Good momentum in many parts of business heading into 2023.
- Alleviating supply chain disruptions.
Challenges Ahead
- Macro-economic volatility.
- Inflationary risks.
- Currency fluctuations.
- Sales will be modestly unfavorably impacted as compared to 2022 if foreign exchange rates hold near their current levels.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...